GOLGA8G Activators
GOLGA8G activators are chemical agents designed to modulate the activity of the protein encoded by the GOLGA8G gene. This gene is one of many in the golgin subfamily A, which are characterized by their coiled-coil domains. The proteins encoded by these genes are predominantly located within the Golgi apparatus, a central organelle involved in various cellular processes including modifying, sorting, and packaging of proteins and lipids for secretion or delivery to other organelles. GOLGA8G, like its counterparts, is thought to play a role in maintaining Golgi structure and potentially in the regulation of Golgi trafficking. Activators of GOLGA8G would interact with this protein, influencing its function and thus affecting the processes it regulates.
The exact mechanisms by which GOLGA8G activators exert their effects are complex and involve a series of molecular interactions. Typically, these molecules would bind to specific sites on the GOLGA8G protein, inducing conformational changes that increase the protein's activity. This might involve the stabilization of the protein structure, enhancement of its affinity for other molecular partners, or modulation of its interactions with membranes or other Golgi-associated proteins. Understanding how these activators work at a molecular level requires detailed knowledge of the protein's structure and the dynamics of the Golgi apparatus. The study of these activators can contribute to the broader understanding of cellular biology by shedding light on the intricate network of protein interactions that underpin Golgi function and cellular homeostasis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, which increases cyclic AMP (cAMP) levels in cells. Elevated cAMP activates PKA (protein kinase A), which can phosphorylate various proteins including those involved in the Golgi apparatus function, potentially enhancing GOLGA8G activity related to Golgi maintenance and vesicle trafficking. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in many signaling pathways, including those regulating Golgi apparatus dynamics. Activation of PKC could influence GOLGA8G function by modulating Golgi membrane trafficking. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a catechin found in green tea that has been shown to inhibit several protein kinases. This inhibition may reduce phosphorylation on competing pathways, thus potentially enhancing signaling pathways that activate GOLGA8G function within the Golgi apparatus. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the structure and function of the Golgi apparatus by inhibiting ADP-ribosylation factor (Arf), which could lead to a compensatory increase in GOLGA8G activity as the cell attempts to maintain Golgi integrity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can lead to the accumulation of ubiquitinated proteins, potentially enhancing the demand for GOLGA8G activity in protein sorting and vesicle formation within the Golgi apparatus. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, which can activate calcium-dependent signaling pathways with potential downstream effects on GOLGA8G activity related to vesicle fusion and trafficking. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog. By mimicking cAMP, it activates PKA and could therefore enhance GOLGA8G function indirectly through PKA-mediated signaling pathways. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
Manumycin A is a farnesyltransferase inhibitor, which might influence GOLGA8G by altering the prenylation and function of proteins that interact with the Golgi apparatus, potentially enhancing vesicle trafficking and GOLGA8G function. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of cellular proteins, which could indirectly affect GOLGA8G function by altering Golgi dynamics and membrane trafficking. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubule networks, which could lead to changes in Golgi apparatus positioning and function, potentially enhancing GOLGA8G activity in Golgi structure maintenance and vesicular transport. | ||||||